In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cytopia Ltd.

Division of Gilead Sciences Inc.

Latest From Cytopia Ltd.

Sierra Believes It Can Do Better Than Gilead With JAK Inhibitor Momelotinib

With many on the executive team who worked on the drug previously, Sierra thinks the stalled Phase III compound could be differentiated from Jakafi and others in the myelofibrosis space based on anemia benefit.

Deals Commercial

Deals Of The Week: Teva/Xenon, Biogen Idec/Isis, Bristol-Myers Squibb/The Medicines Company

Amgen’s unexpected buyout of deCode Genetics means the founder’s expensive philosophy of focusing on pioneering science rather than quick-to-market products finally will pay off for the Icelandic firm’s venture capital backers.

BioPharmaceutical Deals

2010 Scrip 100 - Survivors of the shakeout

Crunched credit wiped out many biotech firms in 2009, yet some emerged from the wreckage leaner and stronger. How did they do it, asks Dr Sukaina Virji-Jeganathan.

Metabolic Disorders Cancer

S*BIO's JAK2 inhibitor moves forward after positive early results

The private Singapore company S*BIO has taken its Janus kinase 2 (JAK2) inhibitor SB1518 into Phase II development for myeloproliferative and haematological malignancies following positive findings in early clinical studies.

Cardiovascular Cancer
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Cytopia Pty. Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Gilead Sciences Inc.
  • Senior Management
  • Andrew Macdonald, CEO
    Gavan Flower, CFO
    Christopher J Burns, PhD, Dir., Research
  • Contact Info
  • Cytopia Ltd.
    Phone: (61) 3 9208 4222
    576 Swan St.
    Richmond, 3121